Editorial: Use of 3D Models in Drug Development and Precision Medicine - Advances and Outlook

Prina-Mello, Adriele; Bonacina, Luigi; Staedler, Davide; Movia, Dania

doi:10.3389/fbioe.2021.658941

Scientific article

English

Editorial: Use of 3D Models in Drug Development and Precision Medicine - Advances and Outlook

ContributorsPrina-Mello, Adriele; Bonacina, Luigi

; Staedler, Davide; Movia, Dania

Published inFrontiers in Bioengineering and Biotechnology, vol. 9, no. 658941

Publication date2021

Abstract

Three-dimensional (3D) in vitro models in the drug development pipeline can help selecting the most promising and safe drug candidates at the pre-clinical stage, prior to clinical trials, reducing and sometimes even replacing animal studies in accordance with the “3Rs (Reduction, Refinement and Replacement) principle”.

Keywords

Editorial
Three-dimesnional in vitro model

Affiliation entities

Faculté des sciences / Section de physique

Research groups

Groupe Wolf

Citation (ISO format)

PRINA-MELLO, Adriele et al. Editorial: Use of 3D Models in Drug Development and Precision Medicine - Advances and Outlook. In: Frontiers in Bioengineering and Biotechnology, 2021, vol. 9, n° 658941. doi: 10.3389/fbioe.2021.658941

Article (Published version)

Identifiers

PID : unige:150872
DOI : 10.3389/fbioe.2021.658941

Additional URL for this publicationhttps://www.frontiersin.org/articles/10.3389/fbioe.2021.658941/full

Journal ISSN2296-4185

257views

128downloads

Creation12/04/2021 10:27:00

First validation12/04/2021 10:27:00

Update16/03/2023 00:22:58

Status update16/03/2023 00:22:57

Last indexation31/10/2024 21:48:16

Archive ouverte UNIGE

Editorial: Use of 3D Models in Drug Development and Precision Medicine - Advances and Outlook

Technical informations